Amber D. Steele

Array ( [id] => 10892937 [patent_doc_number] => 08916550 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-12-23 [patent_title] => 'Compounds for modulating TRPV3 function' [patent_app_type] => utility [patent_app_number] => 11/600514 [patent_app_country] => US [patent_app_date] => 2006-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 21 [patent_no_of_words] => 58547 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11600514 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7688834 [patent_doc_number] => 20070105864 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-10 [patent_title] => 'Methods for inhibiting protein kinases' [patent_app_type] => utility [patent_app_number] => 11/598188 [patent_app_country] => US [patent_app_date] => 2006-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 47189 [patent_no_of_claims] => 87 [patent_no_of_ind_claims] => 75 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20070105864.pdf [firstpage_image] =>[orig_patent_app_number] => 11598188 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5016711 [patent_doc_number] => 20070259920 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-08 [patent_title] => 'P2X7, receptor antagonists and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/593773 [patent_app_country] => US [patent_app_date] => 2006-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12469 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0259/20070259920.pdf [firstpage_image] =>[orig_patent_app_number] => 11593773 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9216347 [patent_doc_number] => 08629147 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-01-14 [patent_title] => 'Heterocyclic compounds useful in the treatment of neoplastic diseases, inflammatory disorders and immunomodulatory disorders' [patent_app_type] => utility [patent_app_number] => 11/593191 [patent_app_country] => US [patent_app_date] => 2006-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 51197 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11593191 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4664325 [patent_doc_number] => 20080255232 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-16 [patent_title] => 'Naphthyl Derivatives as Inhibitors of Beta-Amyloid Aggregation' [patent_app_type] => utility [patent_app_number] => 12/090033 [patent_app_country] => US [patent_app_date] => 2006-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14063 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0255/20080255232.pdf [firstpage_image] =>[orig_patent_app_number] => 12090033 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5204456 [patent_doc_number] => 20070025936 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-01 [patent_title] => 'Dry nail polish applique and method of manufacturing same' [patent_app_type] => utility [patent_app_number] => 11/543481 [patent_app_country] => US [patent_app_date] => 2006-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 8798 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0025/20070025936.pdf [firstpage_image] =>[orig_patent_app_number] => 11543481 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4711696 [patent_doc_number] => 20080300222 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-04 [patent_title] => 'Phosphoantigen Salts Of Organic Bases And Methods For Their Crystallization' [patent_app_type] => utility [patent_app_number] => 12/088477 [patent_app_country] => US [patent_app_date] => 2006-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 34975 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0300/20080300222.pdf [firstpage_image] =>[orig_patent_app_number] => 12088477 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5337917 [patent_doc_number] => 20090054381 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-26 [patent_title] => 'METHODS FOR TREATING RESPIRATORY DISORDERS' [patent_app_type] => utility [patent_app_number] => 12/088922 [patent_app_country] => US [patent_app_date] => 2006-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15461 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20090054381.pdf [firstpage_image] =>[orig_patent_app_number] => 12088922 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8398498 [patent_doc_number] => 08268876 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-09-18 [patent_title] => 'Pharmaceutical composition for external use' [patent_app_type] => utility [patent_app_number] => 12/281969 [patent_app_country] => US [patent_app_date] => 2006-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6534 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12281969 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7682237 [patent_doc_number] => 20100022571 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-28 [patent_title] => 'SUBSTITUTED PYRAZOLO [3,4-B]PYRIDINES AS PHOSPHODIESTERASE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/066914 [patent_app_country] => US [patent_app_date] => 2006-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7491 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20100022571.pdf [firstpage_image] =>[orig_patent_app_number] => 12066914 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4760097 [patent_doc_number] => 20080312323 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-18 [patent_title] => 'Inhibition of TNF-alpha-Initiated Response' [patent_app_type] => utility [patent_app_number] => 11/531921 [patent_app_country] => US [patent_app_date] => 2006-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 13859 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0312/20080312323.pdf [firstpage_image] =>[orig_patent_app_number] => 11531921 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6296090 [patent_doc_number] => 20100160359 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-24 [patent_title] => 'Modulators of Metabolism and the Treatment of Disorders Related Thereto' [patent_app_type] => utility [patent_app_number] => 11/992024 [patent_app_country] => US [patent_app_date] => 2006-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13794 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20100160359.pdf [firstpage_image] =>[orig_patent_app_number] => 11992024 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8995108 [patent_doc_number] => 08518993 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-08-27 [patent_title] => 'Combination of bioavailable methionine with at least one essential oil' [patent_app_type] => utility [patent_app_number] => 11/991573 [patent_app_country] => US [patent_app_date] => 2006-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5538 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11991573 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6431548 [patent_doc_number] => 20100152150 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-17 [patent_title] => 'THE APPLICATION OF MARINE STEROID IN PREPARING THE MEDICINE OF TREATING NEURONS DAMAGING' [patent_app_type] => utility [patent_app_number] => 12/376217 [patent_app_country] => US [patent_app_date] => 2006-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 5670 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20100152150.pdf [firstpage_image] =>[orig_patent_app_number] => 12376217 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5474475 [patent_doc_number] => 20090247641 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-01 [patent_title] => 'HYDRAZONE AGENTS TO TREAT CUTANEOUS LESIONS' [patent_app_type] => utility [patent_app_number] => 12/093417 [patent_app_country] => US [patent_app_date] => 2006-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7762 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0247/20090247641.pdf [firstpage_image] =>[orig_patent_app_number] => 12093417 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4740686 [patent_doc_number] => 20080234339 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-25 [patent_title] => 'Reducing Myocardial Damage and the Incidence of Arrhythmia Arising From Loss, Reduction or Interruption in Coronary Blood Flow' [patent_app_type] => utility [patent_app_number] => 12/064077 [patent_app_country] => US [patent_app_date] => 2006-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 14276 [patent_no_of_claims] => 113 [patent_no_of_ind_claims] => 70 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20080234339.pdf [firstpage_image] =>[orig_patent_app_number] => 12064077 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6592256 [patent_doc_number] => 20100130556 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-27 [patent_title] => 'EP2 RECEPTOR AGONISTS' [patent_app_type] => utility [patent_app_number] => 12/063421 [patent_app_country] => US [patent_app_date] => 2006-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18863 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20100130556.pdf [firstpage_image] =>[orig_patent_app_number] => 12063421 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4813895 [patent_doc_number] => 20080194526 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-14 [patent_title] => 'Liquid Formulations' [patent_app_type] => utility [patent_app_number] => 11/997909 [patent_app_country] => US [patent_app_date] => 2006-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5543 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0194/20080194526.pdf [firstpage_image] =>[orig_patent_app_number] => 11997909 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6568306 [patent_doc_number] => 20100234371 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-16 [patent_title] => 'Bicyclic heterocycles, pharmaceutical compositions containing these compounds, the use thereof and processes for the preparation thereof' [patent_app_type] => utility [patent_app_number] => 11/996886 [patent_app_country] => US [patent_app_date] => 2006-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6578 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20100234371.pdf [firstpage_image] =>[orig_patent_app_number] => 11996886 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4664209 [patent_doc_number] => 20080255116 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-16 [patent_title] => 'Quinoline Derivatives as Antibacterial Agents' [patent_app_type] => utility [patent_app_number] => 11/997182 [patent_app_country] => US [patent_app_date] => 2006-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19765 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0255/20080255116.pdf [firstpage_image] =>[orig_patent_app_number] => 11997182 [rel_patent_id] =>[rel_patent_doc_number] =>)